NCT05324540View on ClinicalTrials.gov

A First in Human Evaluation of a Novel Approach to Painless Cardioversion (NAPC) in Patients With Atrial Fibrillation

NAUnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2022

Primary Completion Date

June 30, 2022

Study Completion Date

March 31, 2023

Conditions
Atrial Fibrillation
Interventions
OTHER

Cool therapy

Application of cool therapy. A chilled (between 5C and 10C) instrument will be applied to the oblique sinus while the patient is in atrial fibrillation.

Sponsors
All Listed Sponsors
lead

MediCool Technologies

INDUSTRY

NCT05324540 - A First in Human Evaluation of a Novel Approach to Painless Cardioversion (NAPC) in Patients With Atrial Fibrillation | Biotech Hunter | Biotech Hunter